OnDemand WTP Pricing Research

Tag: Drug Prices

Report highlights significant variation in healthcare costs | Augusta Free Press

Unlike insurers and employers, those without health insurance have very little information to help to negotiate costs. On VHI’s website, consumers can gain leverage by using the average amount health insurance companies approve. “With the release of the 2016 Healthcare Pricing Transparency report, VHI continues to serve as an unbiased resource for consumers trying to […]

Amazon Enters the Pharmacy: Are You Ready? | Pricing Matters

A few weeks ago, Amazon.com, Inc. announced that it will be acquiring PillPack, the full-service online pharmacy that delivers to your door. It is no secret that the Retail Pharmacy landscape is unquestionably challenging, but it is about to get even more aggressively competitive. Are you ready? Retail pharmacies will need to evaluate their current […]

Trump Promises Lower Drug Prices, but Drops Populist Solutions | The New York Times

Trump Promises Lower Drug Prices, but Drops Populist Solutions | The New York Times

WASHINGTON — President Trump vowed on Friday to “bring soaring drug prices back down to earth” by promoting competition among pharmaceutical companies, and he suggested that the government could require drugmakers to disclose prices in their ubiquitous television advertising. But he dropped the popular and populist proposals of his presidential campaign, opting not to have […]

White House advisers cite USC research as basis for potential drug price reforms | USC News

White House advisers cite USC research as basis for potential drug price reforms | USC News

White House advisory council has issued several recommendations for reining in U.S. prescription drug prices and costs, some of which stem directly from the work of the USC Leonard Schaeffer Center for Health Policy and Economics. Voters are increasingly concerned about rising drug prices and health care costs — to the point that two presidential […]

Budget, White Paper Provide Insight Into Trump Administration’s Strategy On Drug Pricing | Health Affairs

Budget, White Paper Provide Insight Into Trump Administration’s Strategy On Drug Pricing | Health Affairs

During his first year in office, President Donald Trump spoke often about the problem of high drug prices but took no action on the subject. President Trump’s new budget proposal and a newly released white paper from the White House Council of Economic Advisors (CEA) aim to change that by laying out a strategy for […]

Pricing Lessons from the Pharmaceutical Industry | Strategic Pricing Solutions

Pricing Lessons from the Pharmaceutical Industry | Strategic Pricing Solutions

Over the past several months, pricing strategies and practices of the pharmaceutical industry have been a subject of discussion, many times for the wrong reasons. In particular, Valeant has come under extreme criticism for raising the prices of its drugs. Another company, Turing Pharmaceuticals raised the price of Daraprim from $13.50 to $750.00, an increase […]

Paper: Toward Value-Based Pricing to Boost Cancer Research and Innovation | Cancer Research

Paper: Toward Value-Based Pricing to Boost Cancer Research and Innovation | Cancer Research

Abstract The high market price of new anticancer agents has stimulated debate about the long-term sustainability of healthcare systems and whether these new agents can continue to be supported by public healthcare or by private insurers. In addition, some drugs have been approved with limited clinical benefit, raising concerns about setting a minimum requirement for […]

Blog: Pricing Strategies that Last | Strategic Pricing Solutions

Blog: Pricing Strategies that Last | Strategic Pricing Solutions

I have written a number of blog posts about pricing strategies and business strategy in general. Setting strategy is fundamentally about making choices regarding where you compete and how you win. A very important part of making those choices is understanding how those choices affect other market constituents over a longer term. More specifically, considering […]

Blog: Don’t Make Your Customers Angry | Strategic Pricing Solutions

Blog: Don’t Make Your Customers Angry | Strategic Pricing Solutions

Earlier this month Turing Pharmaceuticals raised the price of Daraprim from $13.50 to $750.00, an increase of more than 5000%. There were immediate outcries of price gouging from customers who take the anti-malarial and HIV drug, insurers, doctors and politicians. In the wake of the backlash, Turing reversed course last week and returned the drug […]

Blog: Pricing to Value – Gilead Shows the Way | Strategic Pricing Solutions

Blog: Pricing to Value - Gilead Shows the Way | Strategic Pricing Solutions

In late 2013, Gilead Sciences released Sovaldi, a drug that can cure Hepatitis C in 90 days when used in combination with other anti-viral drugs. The initial price was more than $1,000 per day, and the total cost of treatment could exceed $80,000. In spite of a 90% cure rate for a disease that previously […]